Pfizer · NSE: PFIZER · BSE: 500680
Q2 FY24 results · Jul–Sep 2023
Pfizer reported revenue from operations of ₹575.21 crore (down 9.8% from Q2 FY23) and net profit of ₹148.96 crore (down 52.1% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a standalone basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 575.21 | 637.47 | −9.8% | 531.36 | +8.3% |
| Other income | 36.07 | 24.24 | +48.8% | 33.46 | +7.8% |
| Total income | 611.28 | 661.71 | −7.6% | 564.82 | +8.2% |
| Profit before tax | 200.52 | 415.22 | −51.7% | 125.75 | +59.5% |
| Net profit for the period | 148.96 | 311.07 | −52.1% | 93.53 | +59.3% |
| EPS, basic (₹) | 32.56 | 67.99 | −52.1% | 20.44 | +59.3% |
| Net margin (%) | 25.9 | 48.8 | 17.6 |
Standalone
- Filed with BSE
- 30 Oct 2023, 17:31 IST
- Board meeting
- 28 Oct 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE